EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC 3.0

Febuxostat Improves Postprandial Glucose Regulation and Insulin Sensitivity in Hyperuricemic Individuals with Prediabetes or Newly Diagnosed Type 2 Diabetes: A Prospective Cohort Study

Shuang Liu iD, Qingsong Liu, Ronger Gu iD, Mian Wu, Shuo Meng, Le Yan, Qi Chen, Cuiling Zhu, Si Chen, Bei Xu, Fengjing Liu, Haibing Chen

Drug Design, Development and Therapy · 2025

DOI: 10.2147/dddt.s522154 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Shuang Liu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, People's Republic of Ch…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Febuxostat, Prediabetic State, Hyperuricemia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2FebuxostatPrediabetic StateHyperuricemiaInsulin ResistanceBlood GlucoseHumansMaleFemaleMiddle AgedProspective StudiesPostprandial PeriodGlucose Tolerance TestAdultCohort StudiesAged

Stichwörter der Autor:innen

hyperuricemiainsulin sensitivityprediabetestype 2 diabetesβ-cell function

Substanzen

FebuxostatBlood Glucose

Autor:innen und Institutionen

  • Department of Endocrinology and Metabolism, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China.
  • Department of Pharmacy, Heze Municipal hospital, Heze, People's Republic of China.
  • Department of Endocrinology and Metabolism, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, People's Republic of China.
  • Department of Endocrinology and Metabolism, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.

ORCID-Profile: Shuang Liu, Ronger Gu

Zitieren

APA

Liu, S., Liu, Q., Gu, R., Wu, M., Meng, S., Yan, L., Chen, Q., Zhu, C., Chen, S., Xu, B., Liu, F., & Chen, H. (2025). Febuxostat Improves Postprandial Glucose Regulation and Insulin Sensitivity in Hyperuricemic Individuals with Prediabetes or Newly Diagnosed Type 2 Diabetes: A Prospective Cohort Study. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s522154

Vancouver

Liu S, Liu Q, Gu R, Wu M, Meng S, Yan L, et al. Febuxostat Improves Postprandial Glucose Regulation and Insulin Sensitivity in Hyperuricemic Individuals with Prediabetes or Newly Diagnosed Type 2 Diabetes: A Prospective Cohort Study. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s522154

BibTeX
@article{Liu2025,
  author = {Liu, Shuang and Liu, Qingsong and Gu, Ronger and Wu, Mian and Meng, Shuo and Yan, Le and Chen, Qi and Zhu, Cuiling and Chen, Si and Xu, Bei and Liu, Fengjing and Chen, Haibing},
  title = {Febuxostat Improves Postprandial Glucose Regulation and Insulin Sensitivity in Hyperuricemic Individuals with Prediabetes or Newly Diagnosed Type 2 Diabetes: A Prospective Cohort Study},
  journal = {Drug Design, Development and Therapy},
  year = {2025},
  doi = {10.2147/dddt.s522154}
}
Kostenlos starten →